Learn and Connect with Experts from Industry—Leading Manufacturers
Coffee Talks
Enjoy a complimentary coffee and listen in on the latest developments in Additive Manufacturing, Supply Chain Drivers & M&A Trends, POCT Device Design, and more.
Lunch & Learns
Enjoy Lunch on us while industry experts discuss topics ranging from Molding Fundamentals, Medical Device Testing, Cybersecurity, and more.
RSVP for MD&M West’s Coffee Talks and Lunch & Learns, sponsored and hosted by some of the leading companies in advanced manufacturing. We are honored to work with our sponsors to provide you with a diverse lineup of education, real-world case studies, success stories, and business strategies from the industry experts who pioneered them.
Join the manufacturing community for complimentary food, coffee, and refreshments while connecting with peers and exploring hot topics in medical, critical, and advanced manufacturing.
Coffee Talks
Private Equity Buy-and-Build Strategies in MedTech CDMO
Tuesday, February 4, 2025 / 9:45 - 10:30 a.m. | Room 212AB
First Alira Health will share 2024 M&A insights. Then panelists will discuss private equity buy-and-build strategies in the MedTech CDMO industry. Panelists will include private equity fund managers and executives of PE-backed CDMO platforms. » Learn more
Presented by:
Carlo Stimamiglio
Partner, Alira Health at Alira Health
Sponsored by:
Savior or Curse: Chemical Characterization for Medical Devices
Tuesday, February 4, 2025 | 9:45 - 10:30 a.m. | Room: 211AB
Chemical Characterization is one of the aspects of safety evaluation of medical devices. Depending on the circumstances it can be a great savior in getting device to market or a long potentially painful process. While understanding the chemical makeup of the device is an important step in that safety evaluation. It is important to also understand the limitations of what it can tell you. It is important to understand the role of chemical characterization in device approval and how to use the information as part of an overall strategy. This presentation will provide a general overview of the procedures for conducting a chemical characterization, expected outcomes and how that information can be used to support product success, including strategies for when things may not go as hoped.» Learn more
Presented by:
Stephen Doherty
Head, Chemistry, Preclinical Medical Device Development at Labcorp
Sponsored by:
Future-Proofing Your Medical Device Manufacturing
Tuesday, February 4, 2025 | 1:30 -2:30 p.m. | Room: 212AB
As the medical device landscape rapidly evolves, staying ahead of the competition requires more than just innovation and cutting-edge technology. It demands future-proofing your manufacturing and commercialization strategies to meet emerging challenges and capitalize on new opportunities. This session explores how embracing onshore manufacturing, AI-driven processes and modularization in design can address the growing challenges of bringing complex devices to market. Our experts will share insights on how to choose the right OEM partner to ensure operational excellence by embracing innovation that not only meets today’s demands but also positions your company for long-term success. » Learn more
Presented by:
Donald McNeil
Senior Business Development Manager at Tecan
Emily Stelzer
Senior Manager, Solution Engineering at Tecan
Sponsored by:
Modern vs. Traditional Manufacturing: Agility Meets Assurance in Medical Projects
Tuesday, February 4, 2025 | 1:30 - 2:30 a.m. | Room: 211AB
This presentation examines how modern digital manufacturers combine speed and adaptability with advanced inspection capabilities to streamline the transition from prototyping to early production in the medical industry, setting them apart from traditional approaches. We’ll explore the benefits of these agile partners and address the challenges they pose, particularly in meeting the stringent verification and validation requirements of medical projects. Attendees will gain strategies for leveraging certifications, reporting, and other tools to ensure quality and compliance without compromising efficiency. » Learn more
Presented by:
Chris Burda
Field Applications Engineer II at Proto Labs at Protolabs
Sponsored by:
Leveraging AI to Accelerate Submission and approval for ISO 13485-compliant Devices
Wednesday, February 5, 2025 | 9:45 - 10:30 a.m. | Room: 211AB
In this session, learn about how AI will enable you to connect product requirements to test specifications and automatically generate ISO 13485 documentation as an output of test results. During the session, the NI team will discuss the underlying AI technology and provide a demonstration that maps test requirements through documentation creation. » Learn more
Presented by:
Nicholas Keel
Global Business Lead - Life Sciences at NI
Lunch & Learns
Designing for Manufacturability & Product Life Cycle
Tuesday, February 4, 2025 | 11:30 a.m. - 12:45 p.m. | Room: 211AB
Design for Manufacturability (DFM) represents a critical engineering approach that optimizes product development by integrating five key principles: Process, Design, Materials, Environment, and Compliance/Testing. By systematically addressing these elements early in the development cycle, organizations can significantly reduce manufacturing complexity and costs. DFM emphasizes collaborative engagement across engineering and marketing teams, ensuring that product designs are not only technically sound but also economically viable and aligned with market requirements. This holistic strategy enables businesses to create high-performance products that can be efficiently and consistently manufactured, ultimately improving competitive advantage and reducing time-to-market. » Learn more
Presented by:
Ethan Bruyn
Manufacturing Technology Leader at Medbio
Sponsored by:
Mitigate Risk in Medical Device Manufacturing
Tuesday, February 4, 2025 | 11:30 a.m. - 12:45 p.m. | Room: 212AB
Reducing risks related to cost, quality, and time to market is critical to staying competitive in medical device manufacturing. Join Ben Willms, Director of Business Development at Ascential Medical and Life Sciences, for an insightful Lunch & Learn where he will present innovative strategies that empower manufacturers to navigate these challenges.
This session highlights five critical risks that disrupt manufacturing and provides actionable strategies to overcome them. From early collaboration between development and manufacturing to innovative approaches in modular production and Proof of Principle (PoP) studies, you’ll gain insights into reducing risks and driving efficiency at every stage. » Learn more
Presented by:
Ben Willms
Director of Business Development at Ascential Medical & Life Sciences
Sponsored by:
Site Links
Helpful Links
Official Media
Recognitions
#MDMWest